Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on brain & cognitive health. Browse all Brain & Cognitive Health education
Multiple sclerosis (MS) is an immune-mediated disease in which the body’s own defenses attack the myelin that insulates nerve fibers in the brain and spinal cord. MS is not caused by a single gene, but genetics clearly shapes susceptibility. More than 200 genetic regions have been linked to MS risk, and understanding them clarifies why the disease clusters in families and populations.
How genetics contributes to MS risk
MS is a complex, polygenic condition: risk comes from many genetic variants, each adding a small amount, combined with environmental exposures. Having a close relative with MS raises your risk above the general population, but most people with risk variants never develop the disease. Genetics loads the dice; it does not determine the outcome. This is why researchers describe genetic factors in MS as susceptibility, never as certainty.
HLA-DRB1: the strongest genetic signal
The largest single genetic contributor to MS lies in the immune system’s HLA region. The HLA-DRB1*15:01 allele is the best-established MS risk variant, carrying more weight than any other. HLA genes shape how the immune system distinguishes self from non-self, so it makes biological sense that a variant altering immune recognition would influence an autoimmune disease. Carrying HLA-DRB1*15:01 raises risk, but on its own it is neither necessary nor sufficient to cause MS.
IL7R, IL2RA, and immune signaling
Beyond HLA, MS-associated variants cluster in genes that regulate immune cell behavior. IL7R (interleukin-7 receptor), with the variant rs6897932, affects how T cells develop and survive. IL2RA, the interleukin-2 receptor gene, helps regulate immune tolerance. Variants in vitamin D pathway genes such as CYP27B1 have also drawn attention, consistent with the long-observed link between vitamin D status and MS risk. Each points to immune regulation as the biological core of the disease.
Genes are only part of the story
Genetics interacts with strong environmental factors. Epstein-Barr virus infection, low vitamin D and reduced sun exposure, smoking, and living farther from the equator are all associated with higher MS risk. Women are diagnosed two to three times more often than men, and most diagnoses occur between ages 20 and 50. This gene-environment interplay explains why identical twins do not always share an MS diagnosis, even with the same DNA.
Genetic insight, providers, and living with MS
It is important to be clear: genetic testing does not diagnose, treat, prevent, or manage multiple sclerosis. MS is diagnosed by a neurologist using clinical criteria, MRI, and sometimes spinal fluid analysis, and it is managed with care directed entirely by qualified specialists. What genetic insight can offer is context — a fuller understanding of susceptibility factors that you can bring into an informed conversation with your provider about your overall health.
Where PlexusDx fits
The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including immune and vitamin D pathway variants relevant to conditions like MS. It provides pathway-level education — not a diagnosis, treatment, or management plan. PlexusDx tells you about your biology; it does not tell you what to put in your body. Results are delivered through the secure Results Portal.
Frequently Asked Questions
Is multiple sclerosis genetic?
MS has a genetic component but is not directly inherited. More than 200 variants, led by HLA-DRB1*15:01, each add small amounts of risk, combined with environmental factors. Having a relative with MS raises your risk, yet most people with risk variants never develop the disease. Genetics is one contributor among many.
Can genetic testing diagnose MS?
No. Genetic testing describes pathway-level susceptibility, not a diagnosis. MS is diagnosed by a neurologist using clinical evaluation, MRI imaging, and sometimes spinal fluid analysis. Genetic insight is background context that can inform a broader health conversation, but it cannot confirm or rule out multiple sclerosis.
What is the strongest MS risk gene?
HLA-DRB1*15:01 is the single strongest genetic risk factor for MS, part of the immune system’s HLA region that governs self versus non-self recognition. It carries more weight than any other variant, but it is neither necessary nor sufficient to cause MS. Many carriers never develop the disease.
Do environmental factors matter more than genes?
Both matter and interact. Epstein-Barr virus, low vitamin D, smoking, and latitude are strongly associated with MS risk, layered on top of genetic susceptibility. Because identical twins do not always share an MS diagnosis, environment clearly modifies genetic risk. Neither genes nor environment alone determines the outcome.
Want to understand the immune and vitamin D pathways studied in relation to MS? The Precision Peptide Genetic Test offers pathway-level genetic insight you can bring to an informed conversation with your provider.
The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.
This article is part of the PlexusDx Education Hub. Browse all Brain & Cognitive Health education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Genetic Factors in Nail-Biting Behavior and Management
Hay Fever and Allergic Rhinitis: Genetics and Management